AI Visibility Scorecard
Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes
ozempic.com · Healthcare
Somewhat visible. AI bots can read Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 20 times
Claude · Amazon Alexa · Apple Intelligence · Meta AI
#2,127 of 924,334 in Healthcare for AI visibility
85
AI Naming Predictability
iAI names companies like this often · 85/100
More likely to be named than 99% of Healthcare companies
6
AEO Visibility
iBorderline · 5.5/10
25
Muse Index Score
iAI agent readiness
Basic · 25/100
0
AI Adoption
iNone detected · 0/100
About Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes
from our crawl and measurement
Ozempic describes itself simply: "Ozempic® (semaglutide) is a GLP-1 RA type 2 diabetes treatment that is available in an injectable pen or pill. Read Important Safety Information, including Boxed Warning." Its AI visibility score is 5.5 out of 10: the engines can find it, but they do not have much to hold on to.
Our crawl found structured data on the page (MedicalWebPage), a sitemap and a readable heading structure. It is missing an llms.txt file.
AI crawlers have visited 2 times in our tracking, including Applebot (Siri) and ClaudeBot (Anthropic).
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Strong
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Fair
Press and news coverage.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.5/10, Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes has a working base to build on - fixable, and the signals above are where to start.
Frequently Asked Questions
What is the most important information I should know about Ozempic®?
Ozempic® may cause serious side effects, including:Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer.
What are the possible side effects of Ozempic®?
Ozempic® may cause serious side effects, including:inflammation of your pancreas (pancreatitis). Stop using Ozempic® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your backchanges in vision.
Is this your brand?
The exact fixes for Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes.
Source & Attribution
Scored by Engagemii on August 1, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/ozempic
Cite this score: Engagemii (2026). "AEO Score for Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes." Retrieved from https://engagemii.com/aeo/brands/ozempic
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform